Related by context. Frequent words. (Click for all words.) 59 chronic HCV infection 56 familial hypercholesterolemia 56 acute myelogenous leukemia AML 55 Phase 2a trial 55 cystic fibrosis CF 55 nonsense mutation 55 hepatitis C HCV 54 APOE4 54 HCV infected 54 ApoE4 54 chronic HCV 54 diabetic neuropathic pain 54 systemic lupus erythematosus SLE 53 denufosol 53 hypoparathyroidism 53 BRCA2 gene 53 Phase IIa trial 53 lupus nephritis 53 HCV genotype 1 53 T#I mutation 53 Duchenne muscular dystrophy DMD 52 Phase IIa clinical 52 cognitively normal 52 CMV infection 52 nitazoxanide 52 relapsed refractory multiple myeloma 52 multiple ascending dose 52 gastrointestinal stromal tumors 52 VUR 52 Phase 1b clinical 52 Phase 2a clinical 51 Phase 1b trial 51 lymphoma CTCL 51 attention-deficit/hyperactivity disorder ADHD 51 Acute Myeloid Leukemia AML 51 decitabine 51 Phase Ib 51 chronic idiopathic constipation 51 HER2 positive metastatic breast 51 Phase IIb trial 51 NF1 51 single ascending dose 51 Phase IIa clinical trials 51 chronic ITP 51 dose escalation study 51 Arch Intern Med 51 BRCA mutations 51 castration resistant prostate cancer 51 myelofibrosis 51 chronic hepatitis C. 51 mutated genes 51 defective gene 50 placebo controlled clinical 50 HCV infection 50 mutated gene 50 acute myeloid leukemia AML 50 plaque psoriasis 50 B CLL 50 heterozygous 50 double blinded placebo 50 orally bioavailable 50 myelodysplastic syndrome MDS 50 genetic variant 50 LQTS 50 HGS ETR1 50 tanespimycin 50 systemic lupus erythematosus 50 Phase 2b trial 50 RSV infection 50 Ph + ALL 50 hepatitis C virus HCV 50 chronic myeloid leukemia CML 50 Phase 2b study 50 gene variant 50 seliciclib 50 von Willebrand disease 50 hepatitis B virus HBV 50 refractory multiple myeloma 49 phase IIa 49 blinded placebo controlled 49 CERE 49 BLA submission 49 cytomegalovirus CMV 49 hepatitis C virus 49 BRCA2 mutations 49 gene variation 49 nondiabetic 49 Alemtuzumab 49 multicenter study 49 homozygous 49 postherpetic neuralgia 49 TREANDA 49 Amigal 49 pharmacodynamics 49 inflammatory arthritis 49 stable angina 49 cutaneous T cell 49 cervical dysplasia 49 darapladib 49 LY# [003] 49 idiopathic pulmonary fibrosis IPF